Alkem Laboratories shareholding pattern

ALKEM

5486

90.50 (-1.62%)
Last updated on 15 May, 2026 | 15:31 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Alkem Laboratories Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

51.2%

Mutual Fund

15.57%

Insurance

4.18%

Foreign Institutional Investors

10.15%

Domestic Institutional Investors

1.65%

Retail

17.25%

Others

0%

Total Promoters
MAR '26
51.2%

Summary

Alkem Laboratories share holding pattern reports the following shareholding: Alkem Laboratories Total Promoters is at 51.20%, Mutual Fund at 15.57%, Insurance at 4.18%, Foreign Institutional Investors at 10.15%, Domestic Institutional Investors at 1.65%, and Retail at 17.25%. This breakdown provides a quick snapshot of ownership distribution for Alkem Laboratories share holding pattern in 2026-27.

Alkem Laboratories FAQs

As of 05-2026, the promoter shareholding in Alkem Laboratories stands at 51.2% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Alkem Laboratories is 10.15% and 1.65% respectively.

The retail shareholding of the Alkem Laboratories is 17.25%.

Changes in shareholding patterns of Alkem Laboratories can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Alkem Laboratories are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost